Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-035867
Filing Date
2024-08-08
Accepted
2024-08-08 07:04:08
Documents
57
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fhtx-20240630.htm   iXBRL 10-Q 803196
2 EX-31.1 fhtx-20240630xex311.htm EX-31.1 10250
3 EX-31.2 fhtx-20240630xex312.htm EX-31.2 10232
4 EX-32.1 fhtx-20240630xex321.htm EX-32.1 4294
5 EX-32.2 fhtx-20240630xex322.htm EX-32.2 4279
  Complete submission text file 0001628280-24-035867.txt   4433594

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20240630.xsd EX-101.SCH 32526
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fhtx-20240630_cal.xml EX-101.CAL 50433
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fhtx-20240630_def.xml EX-101.DEF 133391
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20240630_lab.xml EX-101.LAB 464416
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20240630_pre.xml EX-101.PRE 300538
60 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20240630_htm.xml XML 492376
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39634 | Film No.: 241185965
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)